Spersatear may be available in the countries listed below.
Ingredient matches for Spersatear
Hypromellose
Hypromellose is reported as an ingredient of Spersatear in the following countries:
- South Africa
International Drug Name Search
Friday, October 28, 2016
Dapson PCH
Dapson PCH may be available in the countries listed below.
Ingredient matches for Dapson PCH
Dapsone
Dapsone is reported as an ingredient of Dapson PCH in the following countries:
- Netherlands
International Drug Name Search
Nor-Q. D
Ingredient matches for Nor-Q.D.
Norethisterone
Norethisterone is reported as an ingredient of Nor-Q.D. in the following countries:
- United States
International Drug Name Search
Juvenile Rheumatoid Arthritis Medications
Definition of Juvenile Rheumatoid Arthritis: A chronic, inflammatory disease that may cause joint or connective tissue damage. The onset occurs before age 16.
Drugs associated with Juvenile Rheumatoid Arthritis
The following drugs and medications are in some way related to, or used in the treatment of Juvenile Rheumatoid Arthritis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Topics under Juvenile Rheumatoid Arthritis
- Juvenile Idiopathic Arthritis (5 drugs)
- Still's Disease (2 drugs)
Learn more about Juvenile Rheumatoid Arthritis
Medical Encyclopedia:
- Juvenile rheumatoid arthritis
Drug List:
Thursday, October 27, 2016
Copaxone
Copaxone is a brand name of glatiramer, approved by the FDA in the following formulation(s):
COPAXONE (glatiramer acetate - injectable; subcutaneous)
Manufacturer: TEVA
Approval date: February 12, 2002
Strength(s): 20MG/ML [RLD]
Has a generic version of Copaxone been approved?
No. There is currently no therapeutically equivalent version of Copaxone available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Copaxone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Copolymer-1 improvements in compositions of copolymers
Patent 5,981,589
Issued: November 9, 1999
Inventor(s): Konfino; Eliezer & Sela; Michael & Teitelbaum; Dvora & Arnon; Ruth
Assignee(s): Yeda Research and Development Co., Ltd.
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.Patent expiration dates:
- May 24, 2014
- May 24, 2014
Copolymer-1 improvements in compositions of copolymers
Patent 6,054,430
Issued: April 25, 2000
Inventor(s): Konfino; Eliezer & Sela; Michael & Teitelbaum; Dvora & Arnon; Ruth
Assignee(s): Yeda Research and Development Co., Ltd.
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.Patent expiration dates:
- May 24, 2014
- May 24, 2014
Copolymer-1 improvements in compositions of copolymers
Patent 6,342,476
Issued: January 29, 2002
Inventor(s): Eliezer; Konfino & Michael; Sela & Dvora; Teitelbaum & Ruth; Arnon
Assignee(s): Yeda Research & Development Company Limited
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.Patent expiration dates:
- May 24, 2014✓
- May 24, 2014
Copolymer-1 improvements on compositions of copolymers
Patent 6,362,161
Issued: March 26, 2002
Inventor(s): Eliezer; Konfino & Michael; Sela & Dvora; Teitelbaum & Ruth; Arnon
Assignee(s): Yeda Research & Development Company Limited
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.Patent expiration dates:
- May 24, 2014✓
- May 24, 2014
Copolymer-1 improvements in compositions of copolymers
Patent 6,620,847
Issued: September 16, 2003
Inventor(s): Eliezer; Konfino & Michael; Sela & Dvora; Teitelbaum & Ruth; Arnon
Assignee(s): Yeda Research and Development Co., Ltd.
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.Patent expiration dates:
- May 24, 2014✓
- May 24, 2014
Copolymer-1 improvements in compositions of copolymers
Patent 6,939,539
Issued: September 6, 2005
Inventor(s): Konfino; Eliezer & Sela; Michael & Teitelbaum; Dvora & Arnon; Ruth
Assignee(s): Yeda Research & Development
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.Patent expiration dates:
- May 24, 2014✓
- May 24, 2014
Copolymer-1 improvements in compositions of copolymers
Patent 7,199,098
Issued: April 3, 2007
Inventor(s): Konfino; Eliezer & Sela; Michael & Teitelbaum; Dvora & Arnon; Ruth
Assignee(s): Yeda Research and Development Co., Ltd.
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.Patent expiration dates:
- May 24, 2014✓
- May 24, 2014
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- February 27, 2012 - INDICATION EXPANDED TO INCLUDE PATIENTS WHO HAVE EXPERIENCED A FIRST CLINICAL EPISODE AND HAVE MRI FEATURES CONSISTENT WITH MULTIPLE SCLEROSIS
See also...
- Copaxone Consumer Information (Drugs.com)
- Copaxone Consumer Information (Wolters Kluwer)
- Copaxone injection Consumer Information (Cerner Multum)
- Copaxone Advanced Consumer Information (Micromedex)
- Copaxone AHFS DI Monographs (ASHP)
- Glatiramer Consumer Information (Wolters Kluwer)
- Glatiramer injection Consumer Information (Cerner Multum)
- Glatiramer Subcutaneous Advanced Consumer Information (Micromedex)
- Glatiramer Acetate AHFS DI Monographs (ASHP)
Nifedipine PCH
Nifedipine PCH may be available in the countries listed below.
Ingredient matches for Nifedipine PCH
Nifedipine
Nifedipine is reported as an ingredient of Nifedipine PCH in the following countries:
- Netherlands
International Drug Name Search
Somatulina Autogel
Somatulina Autogel may be available in the countries listed below.
Ingredient matches for Somatulina Autogel
Lanreotide
Lanreotide acetate (a derivative of Lanreotide) is reported as an ingredient of Somatulina Autogel in the following countries:
- Portugal
- Spain
International Drug Name Search
Olina
Olina may be available in the countries listed below.
Ingredient matches for Olina
Hydrochlorothiazide
Hydrochlorothiazide is reported as an ingredient of Olina in the following countries:
- Dominican Republic
International Drug Name Search
Simvabeta
Simvabeta may be available in the countries listed below.
Ingredient matches for Simvabeta
Simvastatin
Simvastatin is reported as an ingredient of Simvabeta in the following countries:
- Germany
International Drug Name Search
Salocin
Salocin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Salocin
Salinomycin
Salinomycin sodium salt (a derivative of Salinomycin) is reported as an ingredient of Salocin in the following countries:
- United Kingdom
International Drug Name Search
Oxaliplatin Winthrop
Oxaliplatin Winthrop may be available in the countries listed below.
Ingredient matches for Oxaliplatin Winthrop
Oxaliplatin
Oxaliplatin is reported as an ingredient of Oxaliplatin Winthrop in the following countries:
- Czech Republic
- Denmark
- Germany
- Slovenia
- Sweden
International Drug Name Search
Wednesday, October 26, 2016
Vitamine B12 Allergan
Vitamine B12 Allergan may be available in the countries listed below.
Ingredient matches for Vitamine B12 Allergan
Cyanocobalamin
Cyanocobalamin is reported as an ingredient of Vitamine B12 Allergan in the following countries:
- France
International Drug Name Search
Dermasil
Dermasil may be available in the countries listed below.
Ingredient matches for Dermasil
Terbinafine
Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Dermasil in the following countries:
- Israel
International Drug Name Search
Zorkaptil
Zorkaptil may be available in the countries listed below.
Ingredient matches for Zorkaptil
Captopril
Captopril is reported as an ingredient of Zorkaptil in the following countries:
- Serbia
International Drug Name Search
Xyzal
Xyzal is a brand name of levocetirizine, approved by the FDA in the following formulation(s):
XYZAL (levocetirizine dihydrochloride - solution; oral)
Manufacturer: UCB INC
Approval date: January 28, 2008
Strength(s): 2.5MG/5ML [RLD][AA]
XYZAL (levocetirizine dihydrochloride - tablet; oral)
Manufacturer: UCB INC
Approval date: May 25, 2007
Strength(s): 5MG [RLD][AB]
Has a generic version of Xyzal been approved?
A generic version of Xyzal has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Xyzal and have been approved by the FDA:
levocetirizine dihydrochloride solution; oral
Manufacturer: SYNTHON PHARMS
Approval date: November 7, 2011
Strength(s): 2.5MG/5ML [AA]
levocetirizine dihydrochloride tablet; oral
Manufacturer: DR REDDYS LABS LTD
Approval date: February 24, 2011
Strength(s): 5MG [AB]
Manufacturer: GLENMARK GENERICS
Approval date: February 24, 2011
Strength(s): 5MG [AB]
Manufacturer: SYNTHON PHARMS
Approval date: November 26, 2010
Strength(s): 5MG [AB]
Manufacturer: TEVA PHARMS
Approval date: August 22, 2011
Strength(s): 5MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xyzal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Methods for treating allergic disorders using optically pure (-) cetirizine
Patent 5,698,558
Issued: December 16, 1997
Inventor(s): Gray; Nancy M.
Assignee(s): Sepracor, Inc.
Methods are disclosed utilizing optically pure (-) cetirizine for the treatment of seasonal and perennial allergic rhinitis in humans while avoiding the concomitant liability of adverse effects associated with the racemic mixture of cetirizine. The optically pure (-) isomer is also useful for the treatment of allergic asthma.Patent expiration dates:
- September 24, 2012✓
- September 24, 2012✓
- March 24, 2013✓
- September 24, 2012
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- November 25, 2010 - PEDIATRIC EXCLUSIVITY
- August 21, 2012 - NEW PATIENT POPULATION
- February 21, 2013 - PEDIATRIC EXCLUSIVITY
See also...
- Xyzal Consumer Information (Drugs.com)
- Xyzal Consumer Information (Wolters Kluwer)
- Xyzal Solution Consumer Information (Wolters Kluwer)
- Xyzal Consumer Information (Cerner Multum)
- Xyzal Advanced Consumer Information (Micromedex)
- Xyzal AHFS DI Monographs (ASHP)
- Levocetirizine Consumer Information (Wolters Kluwer)
- Levocetirizine Solution Consumer Information (Wolters Kluwer)
- Levocetirizine Consumer Information (Cerner Multum)
- Levocetirizine Advanced Consumer Information (Micromedex)
- Levocetirizine Dihydrochloride AHFS DI Monographs (ASHP)
Nisidol
Nisidol may be available in the countries listed below.
Ingredient matches for Nisidol
Nefopam
Nefopam hydrochloride (a derivative of Nefopam) is reported as an ingredient of Nisidol in the following countries:
- Vietnam
International Drug Name Search
Diproforte
Diproforte may be available in the countries listed below.
Ingredient matches for Diproforte
Betamethasone
Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Diproforte in the following countries:
- Austria
International Drug Name Search
Sinobid
Sinobid may be available in the countries listed below.
Ingredient matches for Sinobid
Norfloxacin
Norfloxacin is reported as an ingredient of Sinobid in the following countries:
- Greece
International Drug Name Search
Zil
Zil may be available in the countries listed below.
Ingredient matches for Zil
Ornidazole
Ornidazole is reported as an ingredient of Zil in the following countries:
- India
International Drug Name Search
Vertigen
Vertigen may be available in the countries listed below.
Ingredient matches for Vertigen
Betahistine
Betahistine is reported as an ingredient of Vertigen in the following countries:
- Colombia
Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Vertigen in the following countries:
- Poland
International Drug Name Search
Zefidim
Zefidim may be available in the countries listed below.
Ingredient matches for Zefidim
Ceftazidime
Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Zefidim in the following countries:
- Indonesia
International Drug Name Search
Tuesday, October 25, 2016
Vitamina K1 GMP
Vitamina K1 GMP may be available in the countries listed below.
Ingredient matches for Vitamina K1 GMP
Phytomenadione
Phytomenadione is reported as an ingredient of Vitamina K1 GMP in the following countries:
- Venezuela
International Drug Name Search
SPS
Ingredient matches for SPS
Polystyrene Sulfonic Acid
Polystyrene Sulfonic Acid sodium salt (a derivative of Polystyrene Sulfonic Acid) is reported as an ingredient of SPS in the following countries:
- United States
International Drug Name Search
Dicloftal
Dicloftal may be available in the countries listed below.
Ingredient matches for Dicloftal
Diclofenac
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Dicloftal in the following countries:
- Portugal
International Drug Name Search
Olmax
Olmax may be available in the countries listed below.
Ingredient matches for Olmax
Olmesartan
Olmesartan Medoxomil is reported as an ingredient of Olmax in the following countries:
- India
International Drug Name Search
Hypotears Gel
Hypotears Gel may be available in the countries listed below.
Ingredient matches for Hypotears Gel
Retinol
Retinol palmitate (a derivative of Retinol) is reported as an ingredient of Hypotears Gel in the following countries:
- Bangladesh
- Czech Republic
- Philippines
- Slovakia
- Slovenia
- Sri Lanka
International Drug Name Search
Ultimag
Ultimag may be available in the countries listed below.
Ingredient matches for Ultimag
Magnesium Chloride
Magnesium Chloride is reported as an ingredient of Ultimag in the following countries:
- South Africa
Zinc Oxide
Zinc Oxide is reported as an ingredient of Ultimag in the following countries:
- South Africa
International Drug Name Search
Lyme Disease, Carditis Medications
Drugs associated with Lyme Disease, Carditis
The following drugs and medications are in some way related to, or used in the treatment of Lyme Disease, Carditis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug List:
Norflodal
Norflodal may be available in the countries listed below.
Ingredient matches for Norflodal
Norfloxacin
Norfloxacin is reported as an ingredient of Norflodal in the following countries:
- Taiwan
International Drug Name Search
Monday, October 24, 2016
Varmec
Varmec may be available in the countries listed below.
Ingredient matches for Varmec
Fluconazole
Fluconazole is reported as an ingredient of Varmec in the following countries:
- Greece
International Drug Name Search
Q-Prost
Q-Prost may be available in the countries listed below.
Ingredient matches for Q-Prost
Finasteride
Finasteride is reported as an ingredient of Q-Prost in the following countries:
- Argentina
International Drug Name Search
Dientamoeba fragilis Medications
Definition of Dientamoeba fragilis:
A species of small amoeba-like flagellates, formerly considered a true amoeba, now recognised as an amebo-flagellate related to Trichomonas.
They are parasitic in the large intestine of humans and certain monkeys, and although usually nonpathogenic, they are believed to be capable causing low-grade inflammation with mucous diarrhoea and gastrointestinal disturbance in humans.
See: Histomonas meleagridis.
Drugs associated with Dientamoeba fragilis
The following drugs and medications are in some way related to, or used in the treatment of Dientamoeba fragilis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug List:
Vfend
In the US, Vfend (voriconazole systemic) is a member of the drug class azole antifungals and is used to treat Aspergillosis - Invasive, Blastomycosis, Candida Infections - Systemic, Coccidioidomycosis - Meningitis, Cutaneous Fungal Infection, Esophageal Candidiasis, Eumycetoma, Fungal Infection - Internal and Disseminated, Fungal Meningitis, Fungal Pneumonia, Fusariosis, Ocular Fungal Infection, Pseudoallescheriosis and Systemic Fungal Infection.
US matches:
- Vfend
- Vfend Suspension
- Vfend Tablets
- Vfend I.V.
- Vfend Oral
UK matches:
- VFEND 50 mg and 200 mg film-coated tablets, VFEND 200 mg powder for solution for infusion,VFEND 40 mg/ml powder for oral suspension (SPC)
Ingredient matches for Vfend
Voriconazole
Voriconazole is reported as an ingredient of Vfend in the following countries:
- Argentina
- Australia
- Austria
- Belgium
- Belize
- Brazil
- Canada
- Chile
- China
- Colombia
- Costa Rica
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- El Salvador
- Finland
- France
- Georgia
- Germany
- Guatemala
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Luxembourg
- Malaysia
- Mexico
- Netherlands
- New Zealand
- Nicaragua
- Norway
- Panama
- Peru
- Poland
- Portugal
- Romania
- Russian Federation
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sweden
- Switzerland
- Taiwan
- Tunisia
- Turkey
- United Kingdom
- United States
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Sunday, October 23, 2016
Desparin
Desparin may be available in the countries listed below.
Ingredient matches for Desparin
Drotaverine
Drotaverine hydrochloride (a derivative of Drotaverine) is reported as an ingredient of Desparin in the following countries:
- Poland
International Drug Name Search
Orphenadrine Hydrochloride
UK matches:
- Orphenadrine Hydrochloride 50mg/5ml Oral Solution
- Orphenadrine Hydrochloride 50mg/5ml Oral Solution (SPC)
Ingredient matches for Orphenadrine Hydrochloride
Orphenadrine
Orphenadrine Hydrochloride (BANM) is known as Orphenadrine in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Doliv
Doliv may be available in the countries listed below.
Ingredient matches for Doliv
Biphenyl dimethyl dicarboxylate
Biphenyl dimethyl dicarboxylate is reported as an ingredient of Doliv in the following countries:
- Vietnam
International Drug Name Search
Nystatin F. T. Pharma
Nystatin F.T. Pharma may be available in the countries listed below.
Ingredient matches for Nystatin F.T. Pharma
Nystatin
Nystatin is reported as an ingredient of Nystatin F.T. Pharma in the following countries:
- Vietnam
International Drug Name Search
Valpron
Valpron may be available in the countries listed below.
Ingredient matches for Valpron
Valproic Acid
Valproic Acid is reported as an ingredient of Valpron in the following countries:
- Venezuela
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valpron in the following countries:
- Venezuela
International Drug Name Search
Oxazepam CF
Oxazepam CF may be available in the countries listed below.
Ingredient matches for Oxazepam CF
Oxazepam
Oxazepam is reported as an ingredient of Oxazepam CF in the following countries:
- Netherlands
International Drug Name Search
Entocort EC
Entocort EC is a brand name of budesonide, approved by the FDA in the following formulation(s):
ENTOCORT EC (budesonide - capsule; oral)
Manufacturer: ASTRAZENECA
Approval date: October 2, 2001
Strength(s): 3MG [RLD][AB]
Has a generic version of Entocort EC been approved?
A generic version of Entocort EC has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Entocort EC and have been approved by the FDA:
budesonide capsule; oral
Manufacturer: MYLAN
Approval date: May 16, 2011
Strength(s): 3MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Entocort EC. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Oral composition for the treatment of inflammatory bowel disease
Patent 5,643,602
Issued: July 1, 1997
Inventor(s): Ulmius; Jan
Assignee(s): Astra Aktiebolag
An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.Patent expiration dates:
- July 1, 2014✓
- January 1, 2015✓✓
- July 1, 2014
See also...
- Entocort EC Sustained-Release Capsules Consumer Information (Wolters Kluwer)
- Entocort EC Consumer Information (Cerner Multum)
- Entocort EC Advanced Consumer Information (Micromedex)
- Budesonide Powder Consumer Information (Wolters Kluwer)
- Budesonide Suspension Consumer Information (Wolters Kluwer)
- Budesonide Sustained-Release Capsules Consumer Information (Wolters Kluwer)
- Budesonide Consumer Information (Cerner Multum)
- Budesonide inhalation Consumer Information (Cerner Multum)
- Pulmicort Spacer Advanced Consumer Information (Micromedex)
- Rhinocort Turbuhaler Advanced Consumer Information (Micromedex)
- Budesonide Advanced Consumer Information (Micromedex)
- Budesonide Inhalation Advanced Consumer Information (Micromedex)
- Budesonide AHFS DI Monographs (ASHP)
Vinorelbin Sindan
Vinorelbin Sindan may be available in the countries listed below.
Ingredient matches for Vinorelbin Sindan
Vinorelbine
Vinorelbine is reported as an ingredient of Vinorelbin Sindan in the following countries:
- Romania
International Drug Name Search
Delta Cortef
Delta Cortef may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Delta Cortef
Prednisolone
Prednisolone is reported as an ingredient of Delta Cortef in the following countries:
- Australia
International Drug Name Search
Deprevex
Deprevex may be available in the countries listed below.
Ingredient matches for Deprevex
Telmisartan
Telmisartan is reported as an ingredient of Deprevex in the following countries:
- Argentina
International Drug Name Search
Zalbion
Zalbion may be available in the countries listed below.
Ingredient matches for Zalbion
Tetryzoline
Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Zalbion in the following countries:
- Poland
International Drug Name Search
Saturday, October 22, 2016
Nyscan
Nyscan may be available in the countries listed below.
Ingredient matches for Nyscan
Nystatin
Nystatin is reported as an ingredient of Nyscan in the following countries:
- Bangladesh
International Drug Name Search
Prevention of Bladder infection (Cystitis Prophylaxis) Medications
Drugs associated with Prevention of Bladder infection
The following drugs and medications are in some way related to, or used in the treatment of Prevention of Bladder infection. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug List:
Neovlar
Neovlar may be available in the countries listed below.
Ingredient matches for Neovlar
Ethinylestradiol
Ethinylestradiol is reported as an ingredient of Neovlar in the following countries:
- Taiwan
Levonorgestrel
Levonorgestrel is reported as an ingredient of Neovlar in the following countries:
- Taiwan
International Drug Name Search
Novolin Flexpen 30R
Novolin Flexpen 30R may be available in the countries listed below.
Ingredient matches for Novolin Flexpen 30R
Insulin Injection, Biphasic Isophane
Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Novolin Flexpen 30R in the following countries:
- China
International Drug Name Search
Silverit
Silverit may be available in the countries listed below.
Ingredient matches for Silverit
Enalapril
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Silverit in the following countries:
- Italy
International Drug Name Search
Neutrofil
Neutrofil may be available in the countries listed below.
Ingredient matches for Neutrofil
Filgrastim
Filgrastim is reported as an ingredient of Neutrofil in the following countries:
- Argentina
International Drug Name Search
Friday, October 21, 2016
Zaditoma
Zaditoma may be available in the countries listed below.
Ingredient matches for Zaditoma
Ketotifen
Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Zaditoma in the following countries:
- Japan
International Drug Name Search
Sinquan
Sinquan may be available in the countries listed below.
Ingredient matches for Sinquan
Doxepin
Doxepin hydrochloride (a derivative of Doxepin) is reported as an ingredient of Sinquan in the following countries:
- Denmark
- Iceland
- Switzerland
International Drug Name Search
Diethylstilbestrol
In some countries, this medicine may only be approved for veterinary use.
In the US, Diethylstilbestrol is a member of the following drug classes: estrogens, hormones/antineoplastics.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
G03CB02,G03CC05,L02AA01
CAS registry number (Chemical Abstracts Service)
0000056-53-1
Chemical Formula
C18-H20-O2
Molecular Weight
268
Therapeutic Categories
Antineoplastic agent
Estrogen
Chemical Name
Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-
Foreign Names
- Diethylstilbestrolum (Latin)
- Diethylstilbestrol (German)
- Diéthylstilbestrol (French)
- Dietilestilbestrol (Spanish)
Generic Names
- Diethylstilbestrol (OS: BAN)
- Diéthylstilbestrol (OS: DCF)
- Dietilstilbestrolo (OS: DCIT)
- Stilboestrol (OS: BAN)
- Stilboestrolum (IS)
- Stilbol (IS)
- Diethylstilbestrol (PH: BP 2010, USP 32, Ph. Eur. 6)
- Diéthylstilbestrol (PH: Ph. Eur. 6)
- Diethylstilbestrolum (PH: Ph. Eur. 6)
Brand Names
- Destilbenol
Apsen, Brazil - Dietilestilbestrol
Palmagyar, Peru - Distilbène
Gerda, France - Novo Fosfostilben
Sandoz, Argentina - Stilbestrol
Nysco, Taiwan - Stilboestrol (veterinary use)
Apex Laboratories, Australia
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Duphamox
Duphamox may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Duphamox
Amoxicillin
Amoxicillin is reported as an ingredient of Duphamox in the following countries:
- Belgium
- Luxembourg
- Portugal
- United Kingdom
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Duphamox in the following countries:
- Austria
- Belgium
- Finland
- France
- Germany
- Ireland
- Netherlands
- Switzerland
- United Kingdom
International Drug Name Search
Calcineurin inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
See also
Medical conditions associated with calcineurin inhibitors:
- Cogan's Syndrome
- Crohn's Disease
- Evan's Syndrome
- Focal Segmental Glomerulosclerosis
- Graft-versus-host disease
- Idiopathic Thrombocytopenic Purpura
- Inflammatory Bowel Disease
- Nephrotic Syndrome
- Organ Transplant, Rejection Prophylaxis
- Organ Transplant, Rejection Reversal
- Pemphigoid
- Pemphigus
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Ulcerative Colitis
- Ulcerative Colitis, Active
Drug List:
Dog Net
Dog Net may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Dog Net
Permethrin
Permethrin is reported as an ingredient of Dog Net in the following countries:
- France
International Drug Name Search
Optovit E
Optovit E may be available in the countries listed below.
Ingredient matches for Optovit E
Tocopherol, α-
Tocopherol, α- is reported as an ingredient of Optovit E in the following countries:
- Belgium
International Drug Name Search
Thursday, October 20, 2016
Ulsanic
Ulsanic may be available in the countries listed below.
Ingredient matches for Ulsanic
Sucralfate
Sucralfate is reported as an ingredient of Ulsanic in the following countries:
- Hong Kong
- Israel
- South Africa
- Taiwan
- Thailand
International Drug Name Search
Spralyn
Spralyn may be available in the countries listed below.
Ingredient matches for Spralyn
Cromoglicic Acid
Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Spralyn in the following countries:
- Mexico
International Drug Name Search
Mycoplasma Pneumonia Medications
Definition of Mycoplasma Pneumonia: Mycoplasma pneumonia is an infection of the lungs caused by
Drugs associated with Mycoplasma Pneumonia
The following drugs and medications are in some way related to, or used in the treatment of Mycoplasma Pneumonia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Learn more about Mycoplasma Pneumonia
Medical Encyclopedia:
- Mycoplasma pneumonia
Drug List:
Nafazol
Nafazol may be available in the countries listed below.
Ingredient matches for Nafazol
Naphazoline
Naphazoline is reported as an ingredient of Nafazol in the following countries:
- Serbia
Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Nafazol in the following countries:
- Venezuela
Oxymetazoline
Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Nafazol in the following countries:
- Colombia
International Drug Name Search
Doggy-Doggy
Doggy-Doggy may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Doggy-Doggy
Carbaril
Carbaril is reported as an ingredient of Doggy-Doggy in the following countries:
- Portugal
Dimpylate
Dimpylate is reported as an ingredient of Doggy-Doggy in the following countries:
- Portugal
International Drug Name Search
Dogalact
Dogalact may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Dogalact
Danazol
Danazol is reported as an ingredient of Dogalact in the following countries:
- France
- Luxembourg
Megestrol
Megestrol 17α-acetate (a derivative of Megestrol) is reported as an ingredient of Dogalact in the following countries:
- France
International Drug Name Search
Wednesday, October 19, 2016
Dopegyt
Dopegyt may be available in the countries listed below.
Ingredient matches for Dopegyt
Methyldopa
Methyldopa is reported as an ingredient of Dopegyt in the following countries:
- Bulgaria
- Egypt
- Ethiopia
- Georgia
- Hong Kong
- Hungary
- Latvia
- Lithuania
- Malaysia
- Poland
- Romania
- Russian Federation
- Singapore
- Slovakia
- Sri Lanka
- Syria
- Thailand
- Vietnam
- Yemen
Methyldopa sesquihydrate (a derivative of Methyldopa) is reported as an ingredient of Dopegyt in the following countries:
- Czech Republic
- Germany
International Drug Name Search
Zevalin
In the US, Zevalin (ibritumomab systemic) is a member of the following drug classes: CD20 monoclonal antibodies, radiologic conjugating agents and is used to treat Non-Hodgkin's Lymphoma.
US matches:
- Zevalin In-111
- Zevalin Y-90
- Zevalin
UK matches:
- Zevalin 1.6 mg/ml, Kit for radiopharmaceutical preparation for infusion (SPC)
Ingredient matches for Zevalin
Ibritumomab
Ibritumomab Tiuxetan is reported as an ingredient of Zevalin in the following countries:
- Austria
- Belgium
- Canada
- Croatia (Hrvatska)
- Finland
- France
- Germany
- Hungary
- Ireland
- Israel
- Italy
- Luxembourg
- Netherlands
- Norway
- Poland
- Romania
- Slovenia
- South Africa
- Sweden
- Switzerland
- Turkey
- United Kingdom
- United States
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Spermatex
Spermatex may be available in the countries listed below.
Ingredient matches for Spermatex
Benzalkonium Chloride
Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Spermatex in the following countries:
- Russian Federation
International Drug Name Search
Halonix
Halonix may be available in the countries listed below.
Ingredient matches for Halonix
Hyaluronic Acid
Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Halonix in the following countries:
- India
International Drug Name Search
Debricalm
Debricalm may be available in the countries listed below.
Ingredient matches for Debricalm
Trimebutine
Trimebutine maleate (a derivative of Trimebutine) is reported as an ingredient of Debricalm in the following countries:
- France
International Drug Name Search
Veltex
Veltex may be available in the countries listed below.
Ingredient matches for Veltex
Diclofenac
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Veltex in the following countries:
- South Africa
International Drug Name Search
Vimotadine
Vimotadine may be available in the countries listed below.
Ingredient matches for Vimotadine
Dihydroergotoxine
Dihydroergotoxine mesilate (a derivative of Dihydroergotoxine) is reported as an ingredient of Vimotadine in the following countries:
- Argentina
International Drug Name Search
Tuesday, October 18, 2016
Oftan Starine
Oftan Starine may be available in the countries listed below.
Ingredient matches for Oftan Starine
Tetryzoline
Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Oftan Starine in the following countries:
- Finland
International Drug Name Search
DHS Zinc
In the US, DHS Zinc (pyrithione zinc topical) is a member of the drug class miscellaneous topical agents and is used to treat Dandruff and Seborrheic Dermatitis.
US matches:
- DHS Zinc Topical
Ingredient matches for DHS Zinc
Pyrithione Zinc
Pyrithione Zinc is reported as an ingredient of DHS Zinc in the following countries:
- Chile
International Drug Name Search
Vomidone
Vomidone may be available in the countries listed below.
Ingredient matches for Vomidone
Domperidone
Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Vomidone in the following countries:
- Indonesia
International Drug Name Search
Norcolut
Norcolut may be available in the countries listed below.
Ingredient matches for Norcolut
Norethisterone
Norethisterone is reported as an ingredient of Norcolut in the following countries:
- Bangladesh
- Hungary
- Singapore
- Vietnam
International Drug Name Search
Didronat
Didronat may be available in the countries listed below.
Ingredient matches for Didronat
Etidronic Acid
Etidronic Acid disodium salt (a derivative of Etidronic Acid) is reported as an ingredient of Didronat in the following countries:
- Turkey
International Drug Name Search
Novaminsulfon-ratiopharm
Novaminsulfon-ratiopharm may be available in the countries listed below.
Ingredient matches for Novaminsulfon-ratiopharm
Metamizole
Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Novaminsulfon-ratiopharm in the following countries:
- Germany
International Drug Name Search
Sucralfaat Sandoz
Sucralfaat Sandoz may be available in the countries listed below.
Ingredient matches for Sucralfaat Sandoz
Sucralfate
Sucralfate is reported as an ingredient of Sucralfaat Sandoz in the following countries:
- Netherlands
International Drug Name Search
Holisten
Holisten may be available in the countries listed below.
Ingredient matches for Holisten
Atorvastatin
Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Holisten in the following countries:
- Greece
International Drug Name Search
Vinorelbine Ebewe
Vinorelbine Ebewe may be available in the countries listed below.
Ingredient matches for Vinorelbine Ebewe
Vinorelbine
Vinorelbine tartrate (a derivative of Vinorelbine) is reported as an ingredient of Vinorelbine Ebewe in the following countries:
- France
- Netherlands
- New Zealand
International Drug Name Search
Dacisteine
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0018725-37-6
Chemical Formula
C7-H11-N-O4-S
Molecular Weight
205
Therapeutic Category
Mucolytic agent
Chemical Name
N-Acetyl-L-cysteine, acetate (ester)
Foreign Names
- Dacisteinum (Latin)
- Dacistein (German)
- Dacistéine (French)
- Dacisteina (Spanish)
Generic Names
- Dacistéine (OS: DCF)
- Diacetyl-3-mercaptoalanine, N,S- (IS)
- Diacetyl-L-cysteine, N,S- (IS)
- EL 1035 (IS)
Brand Names
- Mucothiol
Jolly-Jatel, France; Pharmaghreb, Tunisia
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Ulticer
Ulticer may be available in the countries listed below.
Ingredient matches for Ulticer
Ranitidine
Ranitidine is reported as an ingredient of Ulticer in the following countries:
- Hong Kong
International Drug Name Search
Norlip
Norlip may be available in the countries listed below.
Ingredient matches for Norlip
Bezafibrate
Bezafibrate is reported as an ingredient of Norlip in the following countries:
- Israel
International Drug Name Search
Monday, October 17, 2016
Nimadorm
Nimadorm may be available in the countries listed below.
Ingredient matches for Nimadorm
Zolpidem
Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Nimadorm in the following countries:
- Denmark
International Drug Name Search
Group I antiarrhythmics
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
See also
Medical conditions associated with group I antiarrhythmics:
- Anesthesia
- Anxiety
- Arrhythmia
- Atrial Fibrillation
- Atrial Flutter
- Burning Mouth Syndrome
- Diabetic Nerve Damage
- Epilepsy
- Malaria
- Neurosurgery
- Paroxysmal Supraventricular Tachycardia
- Peripheral Neuropathy
- Rheumatoid Arthritis
- Seizures
- Status Epilepticus
- Supraventricular Tachycardia
- Trigeminal Neuralgia
- Ventricular Fibrillation
- Ventricular Tachycardia
- Wolff-Parkinson-White Syndrome
Drug List:
Vestax
Vestax may be available in the countries listed below.
Ingredient matches for Vestax
Paracetamol
Paracetamol is reported as an ingredient of Vestax in the following countries:
- Venezuela
International Drug Name Search
Duexis
Duexis is a brand name of famotidine/ibuprofen, approved by the FDA in the following formulation(s):
DUEXIS (famotidine; ibuprofen - tablet; oral)
Manufacturer: HORIZON PHARMA
Approval date: April 23, 2011
Strength(s): 26.6MG;800MG [RLD]
Has a generic version of Duexis been approved?
No. There is currently no therapeutically equivalent version of Duexis available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Duexis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Stable compositions of famotidine and ibuprofen
Patent 8,067,033
Issued: November 29, 2011
Inventor(s): Xu; Jerry & Tidmarsh; George
Assignee(s): Horizon Pharma USA, Inc.
Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments, the ibuprofen is in direct physical contact with the famotidine.Patent expiration dates:
- July 18, 2026✓
- July 18, 2026
Methods and medicaments for administration of ibuprofen
Patent 8,067,451
Issued: November 29, 2011
Inventor(s): Tidmarsh; George & Golombik; Barry L. & Sharma; Puneet
Assignee(s): Horizon Pharma USA, Inc.
A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.Patent expiration dates:
- July 18, 2026✓✓
- July 18, 2026
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- April 23, 2014 - NEW COMBINATION
See also...
- Duexis Consumer Information (Drugs.com)
- Duexis Consumer Information (Wolters Kluwer)
- Duexis Consumer Information (Cerner Multum)
- Duexis Advanced Consumer Information (Micromedex)
- Ibuprofen/Famotidine Consumer Information (Wolters Kluwer)
- Famotidine and ibuprofen Consumer Information (Cerner Multum)
- Ibuprofen and famotidine Advanced Consumer Information (Micromedex)
Vironida
Vironida may be available in the countries listed below.
Ingredient matches for Vironida
Acyclovir
Aciclovir is reported as an ingredient of Vironida in the following countries:
- Chile
International Drug Name Search
Dylix
In the US, Dylix (dyphylline systemic) is a member of the drug class methylxanthines and is used to treat Asthma, Bronchitis and COPD.
US matches:
- Dylix Elixir
- Dylix
Ingredient matches for Dylix
Diprophylline
Diprophylline is reported as an ingredient of Dylix in the following countries:
- United States
International Drug Name Search
Zopiclone Alpharma
Zopiclone Alpharma may be available in the countries listed below.
Ingredient matches for Zopiclone Alpharma
Eszopiclone
Zopiclone is reported as an ingredient of Zopiclone Alpharma in the following countries:
- Finland
International Drug Name Search
Omsil
Omsil may be available in the countries listed below.
Ingredient matches for Omsil
Tamsulosin
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Omsil in the following countries:
- Ireland
International Drug Name Search
Sunday, October 16, 2016
Nitrendipin Heumann
Nitrendipin Heumann may be available in the countries listed below.
Ingredient matches for Nitrendipin Heumann
Nitrendipine
Nitrendipine is reported as an ingredient of Nitrendipin Heumann in the following countries:
- Germany
International Drug Name Search
Dostol
Dostol may be available in the countries listed below.
Ingredient matches for Dostol
Erdosteine
Erdosteine is reported as an ingredient of Dostol in the following countries:
- Peru
International Drug Name Search
Skinox
Skinox may be available in the countries listed below.
Ingredient matches for Skinox
Hydroquinone
Hydroquinone is reported as an ingredient of Skinox in the following countries:
- Indonesia
International Drug Name Search
Subscribe to:
Posts (Atom)